This case report reviews some of the clinical aspects of epidermal growth factor receptor (EGFR) inhibitor-induced rash, and, more importantly, it describes a specific case in which the diagnosis of such a rash occurred by means of a patient-initiated photographic electronic communication. The fact that this electronic communication was patient-initiated suggests that health care providers will likely be asked to make clinical decisions based on this type of communication soon and that this type of seemingly low-cost approach will likely become an important aspect of cancer symptom control and palliative care in the future.
Get full access to this article
View all access options for this article.
References
1.
LacoutureME. The growing importance of skin toxicity in EGFR inhibitor therapy. Oncology, 2009; 23:194196.
2.
SolomonBM, JatoiA. Rash from EGFR inhibitors: Opportunities and challenges for palliation. Curr Oncol Rep, 2008; 10:304–308.
3.
JatoiA, GreenEM, FowlandKMJr. Clinical predictors of severe cetuximab-induced rash: Observations from 933 patients enrolled in North Central Cancer Treatment Group Study N0147. Oncology, 2009; 77:120–123.
4.
WagnerLI, LacoutureME. Dermatologic toxicities associated with EGFR inhibitors: The clinical psychologist's perspective. Impact on health-related quality of life and implications for clinical management of psychological sequelae. Oncology, 2007; 21,Suppl 5:34–36.
5.
JatoiA, NguyenPL. Do patients die from rashes from epidermal growth factor receptor inhibitors? A systematic review to help counsel patients about holding therapy. Oncologist, 2008; 13:1201–1204.
6.
ScopeA, AgeroAL, DiszaSW, MyskowskiPL, LiebJA, SaltzL, KemenyNE, HalpernAC. Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption. J Clin Oncol, 2007; 25:5390–5396.
7.
JatoiA, FowlandK, SloanJA, GrossHM, FishkinPA, KahanicSP, NovotnyPJ, SchaeferPL, JohnsonDB, TschetterLK, LoprinziCL. Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB)Cancer, 2008; 113:847–853.
8.
MaseratE. Information communication technology: New approach for rural cancer care improvement. Asian Pac J Cancer Prev, 2008; 9:811–814.
9.
PhillipsJL, DavidsonPM, NewtonPJ, DigiacomoM. Supporting patients and their caregivers after-hours at the end of life: The role of telephone support. J Pain Symptom Manage, 2008; 36:11–21.
10.
BharadwajP, VasavaS, PisharodiS. Los Angeles to Mumbai: providing palliation using technology. J Palliat Med, 2007; 10:1037–1039.
11.
CzarneckiML, GarwoodMM, WeismanSJ. Advanced practice nurse-directed telephone management of acute pain following pediatric spinal fusion surgery. J Spec Pediatr Nurs, 2007; 12:159–169.
12.
HebertMA, PaquinMJ, WhittenL, CaiP. Analysis of the suitability of ‘video-visits' for palliative home care: Implications for practice. J Telemed Telecare, 2007; 13:74–78.
13.
TeunissenSC, VerhagenEH, BrinkM, van der LindenBA, VoestEE, de GraeffA. Telephone consultation in palliative care for cancer patients: 5 years of experience in The Netherlands. Support Care Cancer, 2007; 15:577–582.
14.
MaudlinJ, KeenJ, KobbR. A road map for the last journey: Home telehealth for holistic end-of-life care. Am J Hosp Palliat Care, 2006; 23:399–403.
15.
HeffnerVA, LyonVB, BrousseauDC, HollandKE, YenK. Store-and-forward teledermatology versus in-person visits: A comparison in pediatric teledermatology clinic. J Am Acad Dermatol, 2009; 60:956–961.
16.
SchreierG, HaynD, KastnerP, KollerS, SalmhoferW, Hofmann-WellenhofR. A mobile-phone based teledermatology system to support self-management of patients suffering from psoriasis. Conf Proc IEEE Eng Med Biol Soc, 2008; 2008:5338–5341.
17.
Moreno-RamirezD, FerrandizL, Ruiz-de-CasasA, Nieto-GarciaA, Moreno-AlvarezP, GaldeanoR, CamachoFM. Economic evaluation of a store-and-forward teledermatology system for skin cancer patients. J Telemed Telecare, 2009; 15:40–45.
18.
EminovicN, de KeizerNF, WyattJC, ter RietG, PeekN, van WeertHC, Bruijnzeel-KoomenCA, BindelsPJ. Teledermatologic consultation and reduction in referrals to dermatologists: A cluster randomized controlled trial. Arch Dermatol, 2009; 145:558–564.
